155 related articles for article (PubMed ID: 32162782)
1. Novel, Dual Target-Directed Annelated Xanthine Derivatives Acting on Adenosine Receptors and Monoamine Oxidase B.
Kuder KJ; Załuski M; Schabikowski J; Latacz G; Olejarz-Maciej A; Jaśko P; Doroz-Płonka A; Brockmann A; Müller CE; Kieć-Kononowicz K
ChemMedChem; 2020 May; 15(9):772-786. PubMed ID: 32162782
[TBL] [Abstract][Full Text] [Related]
2. Novel multi-target directed ligands based on annelated xanthine scaffold with aromatic substituents acting on adenosine receptor and monoamine oxidase B. Synthesis, in vitro and in silico studies.
Załuski M; Schabikowski J; Schlenk M; Olejarz-Maciej A; Kubas B; Karcz T; Kuder K; Latacz G; Zygmunt M; Synak D; Hinz S; Müller CE; Kieć-Kononowicz K
Bioorg Med Chem; 2019 Apr; 27(7):1195-1210. PubMed ID: 30808606
[TBL] [Abstract][Full Text] [Related]
3. 8-Substituted 1,3-dimethyltetrahydropyrazino[2,1-f]purinediones: Water-soluble adenosine receptor antagonists and monoamine oxidase B inhibitors.
Brunschweiger A; Koch P; Schlenk M; Rafehi M; Radjainia H; Küppers P; Hinz S; Pineda F; Wiese M; Hockemeyer J; Heer J; Denonne F; Müller CE
Bioorg Med Chem; 2016 Nov; 24(21):5462-5480. PubMed ID: 27658798
[TBL] [Abstract][Full Text] [Related]
4. 1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases.
Koch P; Akkari R; Brunschweiger A; Borrmann T; Schlenk M; Küppers P; Köse M; Radjainia H; Hockemeyer J; Drabczyńska A; Kieć-Kononowicz K; Müller CE
Bioorg Med Chem; 2013 Dec; 21(23):7435-52. PubMed ID: 24139167
[TBL] [Abstract][Full Text] [Related]
5. 8-Benzyltetrahydropyrazino[2,1-f]purinediones: water-soluble tricyclic xanthine derivatives as multitarget drugs for neurodegenerative diseases.
Brunschweiger A; Koch P; Schlenk M; Pineda F; Küppers P; Hinz S; Köse M; Ullrich S; Hockemeyer J; Wiese M; Heer J; Müller CE
ChemMedChem; 2014 Aug; 9(8):1704-24. PubMed ID: 24817533
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists.
Petzer JP; Steyn S; Castagnoli KP; Chen JF; Schwarzschild MA; Van der Schyf CJ; Castagnoli N
Bioorg Med Chem; 2003 Apr; 11(7):1299-310. PubMed ID: 12628657
[TBL] [Abstract][Full Text] [Related]
7. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
[TBL] [Abstract][Full Text] [Related]
8. Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones.
Stössel A; Schlenk M; Hinz S; Küppers P; Heer J; Gütschow M; Müller CE
J Med Chem; 2013 Jun; 56(11):4580-96. PubMed ID: 23631427
[TBL] [Abstract][Full Text] [Related]
9. The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues.
Van der Walt MM; Terre'Blanche G; Petzer A; Petzer JP
Bioorg Chem; 2015 Apr; 59():117-23. PubMed ID: 25746740
[TBL] [Abstract][Full Text] [Related]
10. Dual inhibition of monoamine oxidase B and antagonism of the adenosine A(2A) receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues.
Pretorius J; Malan SF; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2008 Sep; 16(18):8676-84. PubMed ID: 18723354
[TBL] [Abstract][Full Text] [Related]
11. Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold.
Cruz-Monteagudo M; Borges F; Cordeiro MNDS; Helguera AM; Tejera E; Paz-Y-Mino C; Sanchez-Rodriguez A; Perera-Sardina Y; Perez-Castillo Y
Curr Neuropharmacol; 2017 Nov; 15(8):1117-1135. PubMed ID: 28093976
[TBL] [Abstract][Full Text] [Related]
12. Fusing Docking Scoring Functions Improves the Virtual Screening Performance for Discovering Parkinson's Disease Dual Target Ligands.
Perez-Castillo Y; Helguera AM; Cordeiro MNDS; Tejera E; Paz-Y-Mino C; Sanchez-Rodriguez A; Borges F; Cruz-Monteagudo M
Curr Neuropharmacol; 2017 Nov; 15(8):1107-1116. PubMed ID: 28067172
[TBL] [Abstract][Full Text] [Related]
13. Probing Substituents in the 1- and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity.
Koch P; Brunschweiger A; Namasivayam V; Ullrich S; Maruca A; Lazzaretto B; Küppers P; Hinz S; Hockemeyer J; Wiese M; Heer J; Alcaro S; Kiec-Kononowicz K; Müller CE
Front Chem; 2018; 6():206. PubMed ID: 29998095
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro evaluation of pteridine analogues as monoamine oxidase B and nitric oxide synthase inhibitors.
Prins LH; Petzer JP; Malan SF
Bioorg Med Chem; 2009 Nov; 17(21):7523-30. PubMed ID: 19804982
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase B inhibition and neuroprotection: studies on selective adenosine A2A receptor antagonists.
Castagnoli N; Petzer JP; Steyn S; Castagnoli K; Chen JF; Schwarzschild MA; Van der Schyf CJ
Neurology; 2003 Dec; 61(11 Suppl 6):S62-8. PubMed ID: 14663013
[TBL] [Abstract][Full Text] [Related]
16. 2-Heteroarylidene-1-indanone derivatives as inhibitors of monoamine oxidase.
Nel MS; Petzer A; Petzer JP; Legoabe LJ
Bioorg Chem; 2016 Dec; 69():20-28. PubMed ID: 27662218
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A
Rohilla S; Bansal R; Kachler S; Klotz KN
Bioorg Chem; 2019 Jun; 87():601-612. PubMed ID: 30933785
[TBL] [Abstract][Full Text] [Related]
18. Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies.
Chavarria D; Fernandes C; Silva V; Silva C; Gil-Martins E; Soares P; Silva T; Silva R; Remião F; Oliveira PJ; Borges F
Eur J Med Chem; 2020 Jan; 185():111770. PubMed ID: 31711793
[TBL] [Abstract][Full Text] [Related]
19. 8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A
Załuski M; Schabikowski J; Jaśko P; Bryła A; Olejarz-Maciej A; Kaleta M; Głuch-Lutwin M; Brockmann A; Hinz S; Zygmunt M; Kuder K; Latacz G; Vielmuth C; Müller CE; Kieć-Kononowicz K
Bioorg Chem; 2020 Aug; 101():104033. PubMed ID: 32629282
[TBL] [Abstract][Full Text] [Related]
20. (E)-8-(3-Chlorostyryl)-1,3,7-trimethylxanthine, a caffeine derivative acting both as antagonist of adenosine A2A receptors and as inhibitor of MAO-B.
Frédérick R; Ooms F; Castagnoli N; Petzer JP; Feng JF; Schwarzschild MA; Van der Schyf CJ; Wouters J
Acta Crystallogr C; 2005 Sep; 61(Pt 9):o531-2. PubMed ID: 16143772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
